Healthcare Reform
The Yin and the Yang of the HCR Decision
Last week's historic Supreme Court on Healthcare Reform assures that all the spending will continue; all the new Board appointments will continue; and all the new bureaucracies will continue to be populated and established. In short, HCR is fully on track for full implementation on January 1, 2014. Or is it? Tom Norton reports ...Read more
Deals
Bristol Myers-Squibb to Acquire Amylin for $5.3 Billion
Bristol-Myers Squibb has agreed to acquire the biopharmaceutical company Amylin Pharmaceuticals for a purchase price of $5.3 billion and an additional $1.7 billion for assuming Amylin’s net debt and contractual payment obligation to Eli Lilly ...Read More
Europe
European Industry Calls for 'New Deal'
Andrew Witty, President of the European pharma industry association EFPIA, is hoping that the deepening European economic crisis will impel European leaders towards more courageous and radical solutions. Reflector reports ...Read More
Digital Pharma
Can Social Media Give Big Pharma Back its Reputation?
Industry's ability to master the external environment depends on making the 140-character shorthand of the Twitter generation its own ...Read more
Advertisement
US Supreme Court Ruling On The Affordable Care Act: Implications For Your Business
Event Date: July 11, 2012 at 11:00 AM EDT
 www.pharmexec.com/supremecourt |
Technology
Gamification Grows Up
Companies using game mechanics to encourage specific patient behavior is nothing new in Big Pharma, but the game is changing fast, driven by two major changes in the way technology can be applied to broaden the patient experience in healthcare ...Read more
 |
